Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1016)
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
75,801
Price
$48.61
Total Value
$3.68M
Shares Held After
2,113,134
% of Holdings
3.5%
GENELUX Corp (GNLX)
Smalling Ralph — Head of Regulatory
Shares
270
Price
$2.98
Total Value
$804.49
Shares Held After
67,803
% of Holdings
0.4%
GENELUX Corp (GNLX)
Cappello Joseph — Chief Technical Officer
Shares
605
Price
$2.97
Total Value
$1.80K
Shares Held After
154,549
% of Holdings
0.4%
GENELUX Corp (GNLX)
Zindrick Thomas — President and CEO
Shares
2,798
Price
$2.94
Total Value
$8.23K
Shares Held After
532,051
% of Holdings
0.5%
GENELUX Corp (GNLX)
Yu Yong — Chief Scientific Officer
Shares
605
Price
$2.97
Total Value
$1.80K
Shares Held After
149,706
% of Holdings
0.4%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
33,948
Price
$0.67
Total Value
$22.75K
Shares Held After
1,239,060
% of Holdings
2.7%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$41.50
Total Value
$1.04M
Shares Held After
1,298,095
% of Holdings
1.9%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
5,812
Price
$0.67
Total Value
$3.89K
Shares Held After
413,001
% of Holdings
1.4%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
81,678
Price
$0.67
Total Value
$54.72K
Shares Held After
5,804,290
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$580.44
Total Value
$69.65K
Shares Held After
40,513
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
514
Price
$579.85
Total Value
$298.04K
Shares Held After
40,633
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
227
Price
$578.73
Total Value
$131.37K
Shares Held After
41,147
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
964
Price
$577.80
Total Value
$557.00K
Shares Held After
41,374
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
210
Price
$576.93
Total Value
$121.15K
Shares Held After
42,338
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
658
Price
$575.33
Total Value
$378.56K
Shares Held After
42,548
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
578
Price
$574.38
Total Value
$331.99K
Shares Held After
43,206
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
397
Price
$573.18
Total Value
$227.55K
Shares Held After
43,784
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,292
Price
$572.39
Total Value
$739.52K
Shares Held After
44,181
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,356
Price
$571.43
Total Value
$774.85K
Shares Held After
45,473
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,019
Price
$570.21
Total Value
$1.15M
Shares Held After
46,829
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,165
Price
$569.50
Total Value
$663.47K
Shares Held After
48,848
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$580.45
Total Value
$46.44K
Shares Held After
18,876
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
591
Price
$579.80
Total Value
$342.66K
Shares Held After
18,956
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
476
Price
$578.42
Total Value
$275.33K
Shares Held After
19,547
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
893
Price
$577.59
Total Value
$515.79K
Shares Held After
20,023
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
89
Price
$576.68
Total Value
$51.32K
Shares Held After
20,916
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
530
Price
$575.26
Total Value
$304.89K
Shares Held After
21,005
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
661
Price
$574.57
Total Value
$379.79K
Shares Held After
21,535
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
480
Price
$573.22
Total Value
$275.15K
Shares Held After
22,196
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,356
Price
$572.32
Total Value
$776.07K
Shares Held After
22,676
% of Holdings
5.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,496
Price
$571.42
Total Value
$854.85K
Shares Held After
24,032
% of Holdings
5.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,059
Price
$570.17
Total Value
$1.17M
Shares Held After
25,528
% of Holdings
7.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,289
Price
$569.46
Total Value
$734.04K
Shares Held After
27,587
% of Holdings
4.5%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Jerrold B — Director
Shares
12,500
Price
$8.01
Total Value
$100.12K
Shares Held After
501,384
% of Holdings
2.5%
Ascendis Pharma A/S (ASND)
JENSEN FLEMMING STEEN — EVP & Product Supply and Quality
Shares
19,460
Price
$238.49
Total Value
$4.64M
Shares Held After
0
% of Holdings
100.0%
Arcus Biosciences, Inc. (RCUS)
Goeltz II Robert C. — Chief Financial Officer
Shares
7,763
Price
$25.63
Total Value
$198.97K
Shares Held After
84,161
% of Holdings
8.4%
FENNEC PHARMACEUTICALS INC. (FENC)
RALLIS CHRIS A — Director
Shares
8,346
Price
$7.04
Total Value
$58.76K
Shares Held After
63,077
% of Holdings
11.7%
Caris Life Sciences, Inc. (CAI)
Vacirca Jeff L — Director
Shares
31,050
Price
$16.15
Total Value
$501.43K
Shares Held After
49,671
% of Holdings
62.5%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
5,808
Price
$30.56
Total Value
$177.49K
Shares Held After
162,331
% of Holdings
3.5%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
6,979
Price
$30.04
Total Value
$209.65K
Shares Held After
168,139
% of Holdings
4.0%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
846
Price
$28.70
Total Value
$24.28K
Shares Held After
175,118
% of Holdings
0.5%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
284
Price
$27.61
Total Value
$7.84K
Shares Held After
175,964
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
5,890
Price
$30.56
Total Value
$180.00K
Shares Held After
1,512,329
% of Holdings
0.4%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
6,871
Price
$30.04
Total Value
$206.40K
Shares Held After
1,518,219
% of Holdings
0.5%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
877
Price
$28.70
Total Value
$25.17K
Shares Held After
1,525,090
% of Holdings
0.1%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
342
Price
$27.57
Total Value
$9.43K
Shares Held After
1,525,967
% of Holdings
0.0%
ABEONA THERAPEUTICS INC. (ABEO)
Vasanthavada Madhav — Chief Commercial Officer
Shares
5,548
Price
$5.96
Total Value
$33.07K
Shares Held After
313,071
% of Holdings
1.7%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
184,639
Price
$46.22
Total Value
$8.53M
Shares Held After
2,671,822
% of Holdings
6.5%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
184,639
Price
$46.22
Total Value
$8.53M
Shares Held After
2,671,822
% of Holdings
6.5%
Kymera Therapeutics, Inc. (KYMR)
Ridloff Elena — Director
Shares
3,000
Price
$87.00
Total Value
$261.00K
Shares Held After
0
% of Holdings
100.0%
Showing 601–650 of 1016 transactions (page 13 of 21)